These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15687142)

  • 1. Cardiovascular risks of coxibs: the orthopaedic perspective.
    Bhattacharyya T; Smith RM
    J Bone Joint Surg Am; 2005 Feb; 87(2):245-6. PubMed ID: 15687142
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective cyclooxygenase inhibition: its role in pain and anaesthesia.
    Langford RM; Mehta V
    Biomed Pharmacother; 2006 Aug; 60(7):323-8. PubMed ID: 16837162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
    Hur C; Chan AT; Tramontano AC; Gazelle GS
    Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The status of coxibs].
    Künzel D
    Krankenpfl J; 2004; 42(7-10):237. PubMed ID: 15675400
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical agents for the management of musculoskeletal pain.
    Stanos SP
    J Pain Symptom Manage; 2007 Mar; 33(3):342-55. PubMed ID: 17349504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach to managing musculoskeletal pain: acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs?
    Hunt RH; Choquette D; Craig BN; De Angelis C; Habal F; Fulthorpe G; Stewart JI; Turpie AG; Davis P
    Can Fam Physician; 2007 Jul; 53(7):1177-84. PubMed ID: 17872814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse cardiovascular effects of the coxibs.
    Dogné JM; Supuran CT; Pratico D
    J Med Chem; 2005 Apr; 48(7):2251-7. PubMed ID: 15801815
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiovascular risk: a class effect of coxibs? How to manage patients taking Vioxx?].
    Brune K; Zacher J
    MMW Fortschr Med; 2004 Oct; 146(42):10, 12. PubMed ID: 15536697
    [No Abstract]   [Full Text] [Related]  

  • 9. Current and emerging treatments for mild/moderate acute ambulatory pain.
    Weaver AL
    Am J Ther; 2008; 15 Suppl 10():S12-6. PubMed ID: 19127123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coxibs and cardiovascular disease.
    Fitzgerald GA
    N Engl J Med; 2004 Oct; 351(17):1709-11. PubMed ID: 15470192
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclooxygenase-2 inhibitors and myocardial infarction.
    Goldstein MR
    Arch Intern Med; 2002 Dec 9-23; 162(22):2639; author reply 2640-2. PubMed ID: 12456258
    [No Abstract]   [Full Text] [Related]  

  • 12. Pain killers--bane or boon? (NSAIDs or COXIBs).
    Joshi SR; Nadkar MY
    J Assoc Physicians India; 2005 Jul; 53():591-2. PubMed ID: 16190125
    [No Abstract]   [Full Text] [Related]  

  • 13. [Withdrawal of rofecoxib: a sign to be careful with coxibs in patients with increased cardiovascular risk].
    Bijlsma JW
    Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2162-4. PubMed ID: 15559407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coxibs: Evolving role in pain management.
    Katz N
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):15-24. PubMed ID: 12528070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain relief at a price. A blow to the heart?
    Comarow A
    US News World Rep; 2001 Sep; 131(8):45. PubMed ID: 11550395
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective COX-2 inhibitors and risk of myocardial infarction.
    Krotz F; Schiele TM; Klauss V; Sohn HY
    J Vasc Res; 2005; 42(4):312-24. PubMed ID: 15976506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is there a future for COX-2 inhibitors?].
    Yodfat Y
    Harefuah; 2004 Nov; 143(11):820-4, 837. PubMed ID: 15603272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Problems of cardiovascular toxicity of coxibs and non-selective NSA].
    Forejtová S
    Vnitr Lek; 2006; 52(7-8):677-85. PubMed ID: 16967608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rheumatology. Do coxibs pose a cardiovascular risk?].
    So A; de Goumoëns P
    Rev Med Suisse; 2005 Jan; 1(2):168-70, 172. PubMed ID: 15773220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.
    Tannenbaum H; Bombardier C; Davis P; Russell AS;
    J Rheumatol; 2006 Jan; 33(1):140-57. PubMed ID: 16331802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.